ScreenerHero

OILSNextleaf Solutions Ltd.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · nextleafsolutions.com
0.0450CADMkt Cap: 4.95M $P/E: —

Nextleaf Solutions Ltd., a cannabis extraction technology company, engages in the manufacture and distribution of cannabinoid vapes, oils, and softgels in Canada. The company is involved in toll processing, bulk ingredie…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
MERCK Kommanditgesellschaft auf Aktien
$65.19BUSDP/E 23.7
TAK
Takeda Pharmaceutical Co. Ltd.
$58.06BUSD
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$43.98BUSDP/E 20.4
TEVA
Teva Pharmaceutical Industries Limited
$43.51BUSDP/E 62.2
ZOE
Zoetis Inc.
$29.89BUSDP/E 12.7
ZTS
Zoetis Inc.
$32.12BUSDP/E 12.7
UTHR
United Therapeutics Corporation
$22.01BUSDP/E 18.4
VTRS
Viatris, Inc.
$18.75BUSD
SOBI
Swedish Orphan Biovitrum AB
$15.34BUSDP/E 117.3
IPN
Ipsen S.A.
$14.67BUSDP/E 26.4
NBIX
Neurocrine Biosciences, Inc.
$15.51BUSDP/E 22.3
ELAN
Elanco Animal Health Incorporat
$11.98BUSD
RDY
Dr. Reddy's Laboratories Ltd
$10.15BUSDP/E 29.7
KRK
Krka, d. d.
$8.66BUSDP/E 19.0
ALKS
Alkermes plc
$8.11BUSDP/E 127.2
HIMS
Hims & Hers Health, Inc.
$7.88BUSD
LNTH
Lantheus Holdings Inc
$6.53BUSDP/E 23.9
AMRX
Amneal Pharmaceuticals, Inc. Class A
$6.24BUSDP/E 37.3
LQDA
Liquidia Corporation
$6.14BUSDP/E 49.0
KNSA
Kiniksa Pharmaceuticals, Ltd.
$6.08BUSDP/E 79.8

Key Statistics

Company
Market Cap4.95M $
Enterprise Value4.93M $
Revenue (TTM)7.49M $
Gross Profit2.76M $
Net Income (TTM)-118.67K $
Revenue/Share0.0444 USD
Last Price0.0450 CAD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA19.78
EV/Revenue0.66
P/S0.66
P/B1.60
EPS (TTM)-0.01
EPS (Forward)—
52W Range
0.0350100% of range0.0400
52W High0.0400 CAD
52W Low0.0350 CAD
Profitability
Gross Margin33.68%
Oper. Margin-9.13%
EBITDA Margin3.32%
Profit Margin-1.45%
ROE-3.56%
ROA-2.08%
Growth
Revenue Growth-31.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF302.14K $
CapEx (TTM)195.02K $
FCF Margin9.00%
FCF Yield13.62%
Net Debt-25.44K $
Net Debt/EBITDA-0.10
Balance Sheet
Debt/Equity0.10
Current Ratio1.49
Quick Ratio0.45
Book Value/Sh0.0250 CAD
Cash/Share0.0030 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:3.5
Split DateMar 11, 2019
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.169.94M
Float167.51M
Insiders1.43%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short32.89K
Short (prev mo.)46.15K
Technical
SMA 500.0464 (-3.0%)
SMA 2000.0514 (-12.4%)
Beta0.91
S&P 52W Chg18.16%
Avg Vol (30d)30.83K
Avg Vol (10d)88.51K
Technical Indicators
RSI (14)49.1
MACD-0.0016
MACD Signal-0.0017
MACD Hist.+0.0001
BB Upper0.0508 CAD
BB Middle0.0447 CAD
BB Lower0.0387 CAD
BB Width27.03%
ATR (14)0.0027 CAD
Vol Ratio (20d)0.72x